We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Expects First Submission Under Global Generic Application Initiative
EMA Expects First Submission Under Global Generic Application Initiative
The European Medicines Agency expects to receive the first generic drug application under a program that lets companies file joint submissions in the EU, Australia, Canada, Taiwan and Switzerland during the fourth quarter of this year.